Concepedia

Elisabeth Losdyck

EL

3

Publications

96

Citations

3

H-Index

2014

Active since

Affiliations

UCLouvain(Current)

de Duve Institute

Ludwig Cancer Research

Cliniques Universitaires Saint-Luc

Istituto Superiore di Sanità

Elisabeth Losdyck is an author at UCLouvain specializing in cell biology, medicine, and signal transduction.

Top concepts

MedicineCell BiologyCell SignalingSignal TransductionGeneticsImmunologyTumor BiologyCancer ResearchMolecular GeneticsJak-stat Signaling Pathway

Publications per year

2014–2016

3

Publications

3

Distinct Acute Lymphoblastic Leukemia (ALL)-associated Janus Kinase 3 (JAK3) Mutants Exhibit Different Cytokine-Receptor Requirements and JAK Inhibitor Specificities

Elisabeth Losdyck, Tekla Hornakova, Lorraine Springuel et al. · Journal of Biological Chemistry · 2015 · 43 citations · Full text

Hematological Malignancy, Cancer Research, Jak Inhibitor Specificities +12

Cooperating JAK1 and JAK3 mutants increase resistance to JAK inhibitors

Lorraine Springuel, Tekla Hornakova, Elisabeth Losdyck et al. · Blood · 2014 · 42 citations · Full text

Loss of mutL homolog-1 (MLH1) expression promotes acquisition of oncogenic and inhibitor-resistant point mutations in tyrosine kinases

Lorraine Springuel, Elisabeth Losdyck, Pascale Saussoy et al. · Cellular and Molecular Life Sciences · 2016 · 11 citations · Full text

Mutl Homolog-1, Signal Transduction, Signaling Pathway +10

Rows per page

1–3 of 3